SAN DIEGO, Dec. 16, 2025 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN) today announced that members of its management team will participate at the following investorSAN DIEGO, Dec. 16, 2025 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN) today announced that members of its management team will participate at the following investor

Illumina To Webcast Upcoming Investor Conference

SAN DIEGO, Dec. 16, 2025 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN) today announced that members of its management team will participate at the following investor conference:

Upcoming Investor Conference

  • 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026

The presentation is scheduled for 7:30 a.m. PT (10:30 a.m. ET), with a Q&A session to follow at approximately 7:50 a.m. PT (10:50 a.m. ET).

The webcast can be accessed through the Events & Presentations section of Illumina’s website at investor.illumina.com. A replay will be archived on Illumina’s website for at least 30 days following the event.

About Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit www.illumina.com and connect with us on X (Twitter), Facebook, LinkedIn, Instagram, TikTok, and YouTube.

Investors:
Conor McNamara
+1.858.291.6421
[email protected]

Media:
Christine Douglass
[email protected]

Cision View original content:https://www.prnewswire.com/news-releases/illumina-to-webcast-upcoming-investor-conference-302643958.html

SOURCE Illumina, Inc.

Market Opportunity
WorldAssets Logo
WorldAssets Price(INC)
$0.5861
$0.5861$0.5861
+0.05%
USD
WorldAssets (INC) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.